Amneal Pharmaceuticals (AMRX) PT Raised to $26 at Morgan Stanley
Tweet
Share
E-mailGet Alerts AMRX Hot Sheet
Price: $18.11 -0.44%
Rating Summary:
6 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
6 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
Morgan Stanley analyst David Risinger raised the price target on Amneal Pharmaceuticals (NYSE: AMRX) to $26.00 (from $22.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Moderna (MRNA) PT Raised to $89 at Morgan Stanley
- CrowdStrike (CRWD) PT Adjusted $250 at Cantor Fitzgerald Post Stock Split
- Baidu (BIDU) PT Lowered to $150 at Benchmark on Near-Term Margin Concerns
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
